Givaudan has announced new strategic investments in its Applied Microbiomics Centre of Excellence, located in Toulouse, France. The move is part of the company’s continued investment in active beauty research and development.
The company will install state-of-the-art automation equipment at the aforementioned center, accelerating the high throughput screenings (HTS) so that it may offer “more disruptive solutions” for its customers.
"Not only are these investments in line with our 2020 company strategy, but our astonishing advancements in microbiomics allow us to bring ground-breaking cosmetic concepts to new and existing customers,” said Givaudan head of active beauty, Laurent Bourdeau. “As the microbiome trend continues to grow, our teams will be at the forefront of this exciting area of scientific research."
Related: Givaudan Announces Executive Committee Changes
Givaudan’s microbiome research has resulted in two award-winning active ingredients. Brightenyl, a microbiome activated skin brightener, won a gold and bronze Innovation Award at the 2015 incosmetics global and Latin American awards, respectively. Then in 2017, Revivyl won gold for Best Innovation at in-cosmetics Latin America and in-cosmetics Asia.
